A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.
Some people who have long lived with the disease say they worry about living as a healthy person, while others worry about the obstacles to getting treatment.